Product Catalog

List Grid

Solution for injection 100 mg/ml 5 ml in ampoules No.10

MILDROCARD-N

MILDROCARD-N

Solution for injection 100 mg/ml 5 ml in ampoules No.10

1 ml of the solution contains 100 mg of 3-(2,2,2- trimethylhydrazinium) propionate dihydrate.

Antihypoxic and cytoprotective product which increases cell load tolerance.

Marketing Authorization No. UA/10376/01/01

Solution for injection 50 mg/ml5 ml in ampoules No.10

Haemaxam

HAEMAXAM

Solution for injection 50 mg/ml5 ml in ampoules No.10

1 ml of the solution contains 50 mg of tranexamic acid.

Starting therapy product used during the hemorrhages of different localization.

 

 

Marketing Authorization No. UA/13418/01/01

Solution for injection 50 mg/ml 2 ml in ampoules No.10

Nikomex 2 ml No.10

NIKOMEX 2 ml No.10

Solution for injection 50 mg/ml 2 ml in ampoules No.10

1 ml of the solution contains 50 mg of ethylmethylhydroxypyridine succinate

Free-radical process inhibitor which increases resistance of the organism to disturbing factors and oxygen-related pathological conditions.

Marketing Authorization No. UA/15072/01/01

Solution for injection 50 mg/ml 5 ml in ampoules No.5

Nikomex 5 ml No.5

NIKOMEX 5 ml No.5

Solution for injection 50 mg/ml 5 ml in ampoules No.5

1 ml of the solution contains 50 mg of ethylmethylhydroxypyridine succinate

Free-radical process inhibitor which increases resistance of the organism to disturbing factors and oxygen-related pathological conditions.

Marketing Authorization No. UA/15072/01/01

Solution for injection 10 mg/ml 1.5 ml in ampoules No.5

Meloxicam-N

MELOXICAM-N

Solution for injection 10 mg/ml 1.5 ml in ampoules No.5

Meloxicam- N is a non-steroid anti-inflammatory drug (NSAID) of enolic acid class, which has anti-inflammatory, analgesic and anti-pyretic effect.

Marketing Authorization No. UA/12990/01/01

Solution for injection 5 mg/ml 10 ml in ampoules No.10.

Bupivacaine

BUPIVACAINE

Solution for injection 5 mg/ml 10 ml in ampoules No.10.

1 ml of the solution contains 5 mg of bupivacaine hydrochloride.

Drug of choice being used for epidural, conduction and infiltration anesthesia if a significant long-lasting effect is needed.

Marketing Authorization No. UA/13416/01/01

Solution for injection 5 mg/ml 4 ml in ampoules No.5

Bupivacaine spinal

BUPIVACAINE SPINAL

Solution for injection 5 mg/ml 4 ml in ampoules No.5

1 ml of the solution contains 5 mg of bupivacaine hydrochloride.

Highly-effective product for spinal anesthesia.

Marketing Authorization No. UA/13417/01/01

Solution for injection 250 mg/ml 2 ml in ampoules No.5

Pharmaxon 2 ml No.5

PHARMAXON 2 ml No.5

Solution for injection 250 mg/ml 2 ml in ampoules No.5

1 ml of the solution contains 250 mg of citicoline.

Psychostimulant and nootropic product.

Marketing  Authorization No. UA/13932/01/01

Solution for injection 250 mg/ml 4 ml in ampoules No.5

Pharmaxon 4 ml No.5

PHARMAXON 4 ml No.5

Solution for injection 250 mg/ml 4 ml in ampoules No.5

1 ml of the solution contains 250 mg of citicoline.

Psychostimulant and nootropic product.

Marketing  Authorization No. UA/13932/01/01

Solution for injection 7.5 mg/ml 2 ml in ampoules No.5

Lasoleks

LASOLEKS

Solution for injection 7.5 mg/ml 2 ml in ampoules No.5, No.20 or No.50.

Mucolytic product. It increases lung secretion, increases lung surfactant release and also stimulates ciliary epithelium activity, which results in better mucus release and its excretion and eases  cough.

Marketing Authorization No. UA/12750/01/01

Раствор для инъекций 100 мг/мл по 5 мл в ампулах №10

Miolocard 5 ml No.10

MIOLOCARD  5 ml No.10

Solution for injection 100 mg/ml 5 ml in ampoules No.10

Active ingredient: 3-(2,2,2- trimethylhydrazinium) propionate dehydrate (meldonium).

1 ml of the solution contains 100 mg of 3-(2,2,2- trimethylhydrazinium) propionate dehydrate (meldonium).

Antihypoxic and cytoprotective product which increases cell load tolerance.

 

Marketing Authorization No. UA/15151/01/01

Solution for injection 20 mg/ml 5 ml in ampoules No.5

Pentoxifylline-N

PENTOXIFYLLINE-N

Solution for injection 20 mg/ml 5 ml in ampoules No.5

The product belongs to the group of peripheral vasodilators. It  blocks aggregation of thrombocytes and erythrocytes, increases their flexibility, reduces the high fibrinogen concentration in blood plasma and increases fibrinolysis which in its turn reduces blood viscosity and improves its rheological properties.

As the result, microcirculation and oxygen supply improvement is observed.

Marketing Authorization No. UA/14521/01/01

Solution for infusion 100 ml of the solution contains 500 mg of levofloxacin

Levocin-N

LEVOCIN-N

Solution for infusion 100 ml of the solution contains 500 mg of levofloxacin.100 and 150 ml in the bottle; 1 bottle per folding box.

The product demonstraters a wide anti-bacterial effect.

Marketing Authorization No. UA/12842/01/01

1 ml of the concentrate contains 500 mg of L-ornithine-L-aspartate;

Gepatox

GEPATOX

Concentrate for solution for infusion 10 ml in ampoules No.10 .1 ml of the concentrate contains 500 mg of L-ornithine-L-aspartate.

Marketing Authorization UA/12890/01/01

Solution for injection 2 mg/ml 2 ml in ampoules No.5

Emeton 2 ml No.5

EMETON 2 ml No.5

Solution for injection 2 mg/ml 2 ml in ampoules No.5

Antiemetic product of central effect, selective antagonist of serotonin receptors 5HT3.

Marketing Authorization No. UA/13447/01/01

Solution for injection 2 mg/ml 4 ml in ampoules No.5

Emeton 4 ml No.5

EMETON 4 ml No.5

Solution for injection 2 mg/ml 4 ml in ampoules No.5

Antiemetic product of central effect, selective antagonist of serotonin receptors 5HT3.

Marketing Authorization No. UA/13447/01/01


To consumersTo specialists To partners
Authorization
*
*
*
*
*
*
Password generation